You are here

  • Home
  • Archive
  • Volume 23, Issue 6
  • Deprescribing cardiovascular drugs in low-risk patients increases the risk of uncontrolled blood pressure and LDL-cholesterol

Article info

Article menu
Download PDFPDF
Commentary
Primary care
Deprescribing cardiovascular drugs in low-risk patients increases the risk of uncontrolled blood pressure and LDL-cholesterol

Authors

  • Daniel Caldeira Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal Centro Cardiovascular daUniversidade de Lisboa - CCUL, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Daniel Caldeira, Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina da Universidade de Lisboa, Lisboa, 1649-028, Portugal; dgcaldeira{at}hotmail.com
View Full Text

Citation

Caldeira D
Deprescribing cardiovascular drugs in low-risk patients increases the risk of uncontrolled blood pressure and LDL-cholesterol
BMJ Evidence-Based Medicine 2018;23:235-236.

Publication history

  • Accepted June 15, 2018
  • First published July 17, 2018.
Online issue publication 
November 22, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.